Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00053989 · OUTCOME

Day 100 TRM

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders · Source last updated 2020-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
from start or conditioning (day -6 or -5) through day +100 after HSC infusion

What was measured

treatment related mortality within 100 days from hematopoietic stem cell (HSC) infusion on day 0

Groups in this outcome

All Patients

All patients enrolled on study

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients41

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
All Patients4Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      41
    units
    Participants
description
treatment related mortality within 100 days from hematopoietic stem cell (HSC) infusion on day 0
groups
  1. description
    All patients enrolled on study
    id
    OG000
    title
    All Patients
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
from start or conditioning (day -6 or -5) through day +100 after HSC infusion
title
Day 100 TRM
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice